Expect Afreeza to be Saved as an Alternative to Rapid-Acting Mealtime Insulin

March 2015

You'll hear about Afrezza (uh-FREZ-uh), a new INHALED insulin for diabetes in adults.

It's now approved in the U.S...and possibly later in Canada.

The first inhaled insulin, Exubera, didn't pan out...partly because the inhaler was hard to use and was about the size of a tennis ball can.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Administration Put a Beyond-Use Date on Meds That are Compounded or Reconstituted
Diabetes Meds Think of Forxiga as Similar to Invokana for Type 2 Diabetes
Vaccines some parents are "on the fence" about whether to vaccinate their children
Pregnancy & Nursing Don't Automatically Override Drug Interaction Alerts Involving Domperidone
Nasal Sprays Don't Be Surprised if Dymista Patients Get a Bitter Taste in Their Mouth
Eating Disorders Expect Vyvanse Doses for Binge Eating to be Similar to ADHD
Men's Health Feel Comfortable Dispensing Tamsulosin to Female patients With Kidney Stones
Psoriasis Watch Dosing for Injectable Biologics for Psoriasis Closely
Insulin Expect Afreeza to be Saved as an Alternative to Rapid-Acting Mealtime Insulin
Pregnancy Alert the Pharmacist to Any Rx or OTC Pain Med Being Used in Pregnant Patients
Readmissions Compare Hospital Discharge Orders to Previous Meds